1 Papers
Jeri Kim is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Prostate cancer & Medicine. The author has co-authored 1 publications.
Chat about Author
Papers
Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment
Yu Jiang,Travis J. Meyers,Adaeze A. Emeka,Lauren Folgosa Cooley,Phillip R. Cooper,Nicola Lancki,Irene Helenowski,Linda Kachuri,Daniel W. Lin,Daniel W. Lin,Janet L. Stanford,Janet L. Stanford,Lisa F. Newcomb,Lisa F. Newcomb,Suzanne Kolb,Suzanne Kolb,Antonio Finelli,Neil E. Fleshner,Maria Komisarenko,James A. Eastham,Behfar Ehdaie,Nicole Benfante,Christopher J. Logothetis,Justin R. Gregg,Cherie Perez,Sergio Garza,Jeri Kim,Leonard S. Marks,Merdie Delfin,Danielle Barsa,Danny Vesprini,Laurence Klotz,Andrew Loblaw,Alexandre Mamedov,S. Larry Goldenberg,Celestia S. Higano,Maria Spillane,Eugenia Wu,H. Ballentine Carter,Christian P. Pavlovich,Mufaddal Mamawala,Tricia Landis,Peter R. Carroll,June M. Chan,Matthew R. Cooperberg,Janet E. Cowan,Todd M. Morgan,Javed Siddiqui,Rabia Martin,Eric A. Klein,Karen Brittain,Paige Gotwald,DA Barocas,Jeremiah R. Dallmer,Jeremiah R. Dallmer,Jennifer B. Gordetsky,Pam Steele,Shilajit Kundu,Jazmine Stockdale,Monique J. Roobol,Lionne D.F. Venderbos,Martin G. Sanda,Rebecca S. Arnold,Dattatraya Patil,Christopher P. Evans,Marc A. Dall'Era,Anjali Vij,Anthony J. Costello,Ken Chow,Niall M. Corcoran,Soroush Rais-Bahrami,Courtney Phares,Douglas S. Scherr,Thomas Flynn,R. Jeffrey Karnes,Michael O. Koch,Courtney Rose Dhondt,Joel B. Nelson,Dawn McBride,Michael S. Cookson,Kelly L. Stratton,Stephen Farriester,Erin Hemken,Walter M. Stadler,Tuula Pera,Deimante Banionyte,Fernando J. Bianco,Isabel H. Lopez,Stacy Loeb,Samir S. Taneja,Nataliya Byrne,Christopher L. Amling,Ann Martinez,Luc Boileau,Franklin Gaylis,Jacqueline Petkewicz,Nicholas Kirwen,Brian T. Helfand,Jianfeng Xu,Denise M. Scholtens,William J. Catalona,John S. Witte +101 more
TL;DR: In this article, a multi-institutional genome-wide association study (GWAS) of 6,361 PC patients who initially elected active surveillance and were followed over time for the potential outcome of conversion from AS to active treatment was conducted.
7